EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pilot study of β-endorphin concentrations in horses with pituitary pars intermedia dysfunction using a newly validated enzyme-linked immunosorbent assay

N Fouché, J Howard, V Gerber, P Billmann, M Farinha do Sul, G Christen, R Bruckmaier, C Philipona, N Besuchet Schmutz, J Gross

Domestic Animal Endocrinology · 2026

DOI: 10.1016/j.domaniend.2025.106982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Domestic Animal Endocrinology, 2026. Verfasst von N Fouché und 9 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Equine Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland. Electronic address: nathalie.fouche@unibe.ch. Hauptthemen laut MEDLINE: beta-Endorphin, Horse Diseases, Pituitary Diseases, Pituitary Gland, Intermediate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss Re Institute, University of Bern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-endorphin, a proopiomelanocortin (POMC)-derived peptide secreted by pars intermedia melanotropes, may play a significant but underexplored role in pituitary pars intermedia dysfunction (PPID) pathophysiology and diagnosis. This study aimed to (1) validate a commercially available human β-endorphin enzyme-linked immunosorbent assay (ELISA) kit for equine samples, and (2) compare β-endorphin concentrations between horses with PPID and healthy controls. Assay validation included the generation of standard curves using purified synthetic equine β-endorphin and human β-endorphin standards, with both curves showing full parallelism. Intra- and inter-assay coefficients of variation (CV) were determined by measuring 37 equine serum samples in duplicate on a single plate and five serum samples across seven different plates. The intra-assay CV was 11.3 % for standards and 5.3 % for equine samples, whereas the inter-assay CV was 6.9 % for standards and 15.6 % for equine samples. Plasma β-endorphin concentrations remained stable over 24 hours regardless of centrifugation timing, storage temperature, or duration. β-endorphin concentrations were determined in five horses with PPID and 20 healthy aged controls. Horses in the PPID group had significantly higher β-endorphin concentrations (median, 506 pg/mL; IQR, 213-762) compared to horses in the control group (median, 35 pg/mL; IQR, 16-55) (P < 0.001). This study may serve as a basis for further research on the role of β-endorphin in horses, particularly in horses with PPID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-EndorphinHorse DiseasesPituitary DiseasesPituitary Gland, IntermediateAnimalsHorsesEnzyme-Linked Immunosorbent AssayPilot ProjectsFemaleMaleReproducibility of Results

Stichwörter der Autor:innen

Adrenocorticotropic hormoneEndocrine disorderEquineGeriatricPPID

Substanzen

beta-Endorphin

Autor:innen und Institutionen

  • Swiss Institute of Equine Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland. Electronic address: nathalie.fouche@unibe.ch.
  • Clinical Diagnostic Laboratory, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Swiss Institute of Equine Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Veterinary Physiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Förderung

  • Swiss Re Institute
  • University of Bern

Zitieren

APA

Fouché, N., Howard, J., Gerber, V., Billmann, P., Farinha do Sul, M., Christen, G., Bruckmaier, R., Philipona, C., Schmutz, N. B., & Gross, J. (2026). Pilot study of β-endorphin concentrations in horses with pituitary pars intermedia dysfunction using a newly validated enzyme-linked immunosorbent assay. Domestic Animal Endocrinology. https://doi.org/10.1016/j.domaniend.2025.106982

Vancouver

Fouché N, Howard J, Gerber V, Billmann P, Farinha do Sul M, Christen G, et al. Pilot study of β-endorphin concentrations in horses with pituitary pars intermedia dysfunction using a newly validated enzyme-linked immunosorbent assay. Domestic Animal Endocrinology. 2026. doi:10.1016/j.domaniend.2025.106982

BibTeX
@article{Fouch2026,
  author = {Fouché, N and Howard, J and Gerber, V and Billmann, P and Farinha do Sul, M and Christen, G and Bruckmaier, R and Philipona, C and Schmutz, N Besuchet and Gross, J},
  title = {Pilot study of β-endorphin concentrations in horses with pituitary pars intermedia dysfunction using a newly validated enzyme-linked immunosorbent assay},
  journal = {Domestic Animal Endocrinology},
  year = {2026},
  doi = {10.1016/j.domaniend.2025.106982}
}
Kostenlos starten →